{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:02:29Z","timestamp":1790089349171,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"DOI":"10.1186\/s13000-026-01832-5","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T23:13:04Z","timestamp":1786057984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Primary acinic cell carcinoma of the breast: insights from a nine-case series and comprehensive literature review"],"prefix":"10.1186","volume":"21","author":[{"given":"Guofeng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aili","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimin","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"1832_CR1","first-page":"e70357","volume":"8","author":"F Skenderi","year":"2025","unstructured":"Skenderi F, Babu GR, Glamoclija U, Veledar E, Gatalica Z, Lamovec J, Vranic S. Acinic cell carcinoma of the breast: a population-based clinicopathologic study. Cancer Rep (Hoboken). 2025;8:e70357.","journal-title":"Cancer Rep (Hoboken)"},{"key":"1832_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/his.12673","volume":"67","author":"S Piscuoglio","year":"2015","unstructured":"Piscuoglio S, Hodi Z, Katabi N, Guerini-Rocco E, Macedo GS, Ng CK, Edelweiss M, DeMattos-Arruda L, Wen HY, Rakha EA, Ellis IO, Rubin BP, Weigelt B, Reis-Filho JS. Are acinic cell carcinomas of the breast and salivary glands distinct diseases? Histopathology. 2015;67:529\u201337.","journal-title":"Histopathology"},{"key":"1832_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/BF00196823","volume":"429","author":"F Roncaroli","year":"1996","unstructured":"Roncaroli F, Lamovec J, Zidar A, Eusebi V. Acinic cell-like carcinoma of the breast. Virchows Arch. 1996;429:69\u201374.","journal-title":"Virchows Arch"},{"key":"1832_CR4","first-page":"813","volume":"30","author":"Y Guo","year":"2023","unstructured":"Guo Y, Li J, He H, Sun P. Clinicopathological features and research progress of acinar cell carcinoma of the breast. J Diagn Pathol. 2023;30:813\u20136.","journal-title":"J Diagn Pathol"},{"key":"1832_CR5","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1158\/1078-0432.CCR-18-1469","volume":"25","author":"T Grellety","year":"2019","unstructured":"Grellety T, Callens C, Richard E, Briaux A, Velasco V, Pulido M, Gon\u00e7alves A, Gestraud P, MacGrogan G, Bonnefoi H, Cardinaud B. Enhancing abiraterone acetate efficacy in androgen receptor-positive triple-negative breast cancer: Chk1 as a potential target. Clin Cancer Res. 2019;25:856\u201367.","journal-title":"Clin Cancer Res"},{"key":"1832_CR6","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/jnci\/djaa201","volume":"113","author":"TO Nielsen","year":"2021","unstructured":"Nielsen TO, Leung SCY, Rimm DL, Dodson A, Acs B, Badve S, Denkert C, Ellis MJ, Fineberg S, Flowers M, Kreipe HH, Laenkholm AV, Pan H, Penault-Llorca FM, Polley MY, Salgado R, Smith IE, Sugie T, Bartlett JMS, McShane LM, Dowsett M, Hayes DF. Assessment of ki67 in Breast Cancer: Updated recommendations from the international ki67 in Breast Cancer Working Group. J Natl Cancer Inst. 2021;113:808\u201319.","journal-title":"J Natl Cancer Inst"},{"key":"1832_CR7","first-page":"268","volume":"27","author":"S Sun","year":"2011","unstructured":"Sun S, Xiang L, Cao D, Shen D. Expression and significance of MMP-2 and MMP-9 in breast carcinoma. Chin J Public Health. 2011;27:268\u201370.","journal-title":"Chin J Public Health"},{"key":"1832_CR8","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10549-023-07153-1","volume":"203","author":"YY Zhao","year":"2024","unstructured":"Zhao YY, Ge HJ, Yang WT, Shao ZM, Hao S. Secretory breast carcinoma: clinicopathological features and prognosis of 52 patients. Breast Cancer Res Treat. 2024;203:543\u201351.","journal-title":"Breast Cancer Res Treat"},{"issue":"8 suppl","key":"1832_CR9","first-page":"s4244","volume":"46","author":"KS McCarty Jr","year":"1986","unstructured":"McCarty KS Jr, Szabo E, Flowers JL, Cox EB, Leight GS. Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors. Cancer Res. 1986;46(8 suppl):s4244\u20138.","journal-title":"Cancer Res"},{"issue":"12","key":"1832_CR10","first-page":"1237","volume":"37","author":"XS Zhang","year":"2021","unstructured":"Zhang XS, Shen R, Miao XB. Expression of PDLIM5 in gastric carcinoma and its clinical significance. J Clin Exp Pathol. 2021;37(12):1237\u201340.","journal-title":"J Clin Exp Pathol"},{"key":"1832_CR11","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/his.12662","volume":"67","author":"E Specht","year":"2015","unstructured":"Specht E, Kaemmerer D, S\u00e4nger J, Wirtz RM, Schulz S, Lupp A. Comparison of immunoreactive score, HER2\/neu score and H score for the immunohistochemical evaluation of somatostatin receptors in bronchopulmonary neuroendocrine neoplasms. Histopathology. 2015;67:368\u201377.","journal-title":"Histopathology"},{"key":"1832_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.semdp.2022.03.001","volume":"39","author":"W Shi","year":"2022","unstructured":"Shi W. Update on selective special types of breast neoplasms: focusing on controversies, differential diagnosis, and molecular genetic advances. Semin Diagn Pathol. 2022;39:367\u201379.","journal-title":"Semin Diagn Pathol"},{"key":"1832_CR13","first-page":"3195","volume":"25","author":"J Zhang","year":"2017","unstructured":"Zhang J, Li Z. Research progress of acinic cell carcinoma of the breast. Mod Oncol. 2017;25:3195\u20137.","journal-title":"Mod Oncol"},{"key":"1832_CR14","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.1200\/JCO.2002.02.005","volume":"20","author":"KD Holen","year":"2020","unstructured":"Holen KD, Klimstra DS, Hummer A. Clinical characteristics and outcomes from an institutional series of acinar cell carcinoma of the pancreas and related tumors. J Clin Oncol. 2020;20:4673\u20138.","journal-title":"J Clin Oncol"},{"key":"1832_CR15","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.breast.2022.10.012","volume":"66","author":"A Ajkunic","year":"2022","unstructured":"Ajkunic A, Skenderi F, Shaker N. Acinic cell carcinoma of the breast: a comprehensive review. Breast. 2022;66:208\u201316.","journal-title":"Breast"},{"key":"1832_CR16","first-page":"1142","volume":"49","author":"K Cheng","year":"2020","unstructured":"Cheng K, Wang X, Wei X, Ma J, Xia QY, Shi QL, Zhou XJ, Rao Q. Expression of NR4A3\/NOR-1 in acinic cell carcinoma of the salivary gland. Chin J Pathol. 2020;49:1142\u20136.","journal-title":"Chin J Pathol"},{"key":"1832_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/pin.13302","volume":"73","author":"T Sugino","year":"2023","unstructured":"Sugino T, Kakuda Y, Yasui H, Oishi T, Norose T, Kawata T, Tadokoro Y, Nishimura S. A case of extensively spreading acinic cell carcinoma of the breast with microglandular features. Pathol Int. 2023;73:45\u201357.","journal-title":"Pathol Int"},{"key":"1832_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2018.06.025","volume":"82","author":"MP Foschini","year":"2018","unstructured":"Foschini MP, Eusebi V. Microglandular adenosis of the breast: a deceptive and still mysterious benign lesion. Hum Pathol. 2018;82:1\u20139.","journal-title":"Hum Pathol"},{"key":"1832_CR19","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/PAS.0000000000002363","volume":"49","author":"F Qin","year":"2025","unstructured":"Qin F, Li J, Zheng Y, Jiang C, Jia Y, Sun H, Xue H, Wang X, Wang L, Qian X, Niu Y, Wen HY, Guo X. Breast carcinomas resembling acinic cell carcinoma: comprehensive analysis of 14 cases and review of the literature. Am J Surg Pathol. 2025;49:448\u201357.","journal-title":"Am J Surg Pathol"},{"key":"1832_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/modpathol.2016.161","volume":"30","author":"FC Geyer","year":"2017","unstructured":"Geyer FC, Berman SH, Marchi\u00f2 C, Burke KA, Guerini-Rocco E, Piscuoglio S, Ng CK, Pareja F, Wen HY, Hodi Z, Schnitt SJ, Rakha EA, Ellis IO, Norton L, Weigelt B, Reis-Filho JS. Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family. Mod Pathol. 2017;30:69\u201384.","journal-title":"Mod Pathol"},{"key":"1832_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.humpath.2018.10.021","volume":"85","author":"CJ Schwartz","year":"2018","unstructured":"Schwartz CJ, Dolgalev I, Yoon E, Osman I, Heguy A, Vega-Saenz de Miera EC, Nimeh D, Jour G, Darvishian F. Microglandular adenosis is an advanced precursor breast lesion with evidence of molecular progression to matrix-producing metaplastic carcinoma. Hum Pathol. 2018;85:65\u201371.","journal-title":"Hum Pathol"},{"key":"1832_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41523-023-00554-x","volume":"9","author":"A Thomas","year":"2023","unstructured":"Thomas A, Reis-Filho JS, Geyer CE Jr, Wen HY. Rare subtypes of triple negative breast cancer: Current understanding and future directions. NPJ Breast Cancer. 2023;9:55.","journal-title":"NPJ Breast Cancer"},{"key":"1832_CR23","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.prp.2016.09.001","volume":"212","author":"S Sherwell-Cabello","year":"2016","unstructured":"Sherwell-Cabello S, Maffuz-Aziz A, Rios-Luna NP, Bautista-Pi\u00f1a V, Rodriguez-Cuevas S. Salivary gland-like breast carcinomas: an infrequent disease. Pathol Res Pract. 2016;212:1034\u20138.","journal-title":"Pathol Res Pract"},{"key":"1832_CR24","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13000-024-01521-1","volume":"19","author":"Y Ge","year":"2024","unstructured":"Ge Y, Wei X, Liu J. Elucidating the nature of acinic cell carcinoma of the breast with high-grade morphology: evidence from case report. Diagn Pathol. 2024;19:100.","journal-title":"Diagn Pathol"},{"key":"1832_CR25","first-page":"1519","volume":"40","author":"S Wei","year":"2025","unstructured":"Wei S, Pei J, Zhang P, Li X. Molecular pathology of adenoid cystic carcinoma. Histol Histopathol. 2025;40:1519\u201328.","journal-title":"Histol Histopathol"},{"key":"1832_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/his.14826","volume":"82","author":"MP Foschini","year":"2023","unstructured":"Foschini MP, Nishimura R, Fabbri VP, Varga Z, Kaya H, Cserni G. Breast lesions with myoepithelial phenotype. Histopathology. 2023;82:53\u201369.","journal-title":"Histopathology"},{"key":"1832_CR27","first-page":"91","volume":"38","author":"L Min","year":"2023","unstructured":"Min L, Qiao H, Zhang H. High grade acinic cell carcinoma of the breast with clear cytoplasm mimics clear cell carcinoma in a BRCA1 mutation carrier: a case report and review of the literature on the molecular analysis. Histol Histopathol. 2023;38:91\u20137.","journal-title":"Histol Histopathol"},{"key":"1832_CR28","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1365-2559.2004.01957.x","volume":"45","author":"F Peintinger","year":"2004","unstructured":"Peintinger F, Leibl S, Reitsamer R. Primary acinic cell carcinoma of the breast: a case report with long-term follow-up and review of the literature. Histopathology. 2004;45:645\u20138.","journal-title":"Histopathology"},{"key":"1832_CR29","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1136\/jcp.55.7.545","volume":"55","author":"JD Coyne","year":"2002","unstructured":"Coyne JD, Dervan PA. Primary acinic cell carcinoma of the breast. J Clin Pathol. 2002;55:545\u20137.","journal-title":"J Clin Pathol"},{"key":"1832_CR30","doi-asserted-by":"publisher","first-page":"102830","DOI":"10.1016\/j.ctrv.2024.102830","volume":"131","author":"Y Lu","year":"2024","unstructured":"Lu Y, Kong X, Wang X, Zhang W, Li Y, Dong H, Wang Z, Gao J, Wang J. Decipheringprimary acinic cell carcinoma of the breast: Insights from a comprehensive case series and systematic review. Cancer Treat Rev. 2024;131:102830.","journal-title":"Cancer Treat Rev"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-026-01832-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-026-01832-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-026-01832-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:21:13Z","timestamp":1790086873000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13000-026-01832-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1832"],"URL":"https:\/\/doi.org\/10.1186\/s13000-026-01832-5","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Ethics Committee of Nanchang People\u2019s Hospital (Approval No. KY2021074). Informed consent was obtained from all individual participants included in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants (or their legal guardians) for publication of this study and any accompanying images\/data.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"65"}}